Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Self -tolerance prevents autoimmunity
- Maintaining self tolerance
- SLE
- Rheumatoid arthritis (RA)
- Multiple sclerosis (MS)
- Protection against autoimmune diseases
- Complement is protective against autoimmunity
- SAP is protective against autoimmunity
- Complement causes death of autoreactive cells
- Complement mediates tolerization
- Studies in mice
- Anti-MBP autoreactive T cells
- Autoreactive T cells are maintained in blood
- Autoreactive T cells induce neuronal damage
- MBP injection induces autoreactive T cells
- Autoreactive T cells are protective
- MBP-specific Th1 cells induce neuroprotection
- Passive transfer of MP-specific Th1 cells
- Autoreactive T cells - dual role
- T reg cells prevent neuroprotection
- Th1 - balance between protective or destructive
- Humoral protective autoimmunity
- Natural antibodies are mostly of IgM
- Natural protective Abs
- Strong activation of C1q - C4
- Early and late response to pathogens
- IgM NA are critical for protection against infection
- Role of natural autoantibodies in autoimmunity
- Non-specific low affinity NAA against self-Ags
- Mechanism for IgM protection in autoimmunity
- NAA are protective against autoimmune diseases
- IgM are beneficial in lupus
- IgM NAA protect against autoimmunity
- IgM anti-dsDNA is beneficial in SLE
- IgM are protective due to minimal deposition
- IgM enhance IC clearance via compliment receptor
- Protective IgM control self-reactive IgG in SLE
- NAA downregulate self-reactive T cells
- IgM are needed for autoimmunity prevention
- The timing of exposure to NIgM is important
- IgM anti-RF is protective in SLE
- Suggested mechanisms for a protective role for RF
- IgM in rheumatoid arthritis
- NAA in IVIG
- Anti-Id Abs in IVIG
- Anti-Id Abs aid to immunocomplex clearance
- Protective antibodies in IVIG - modes of action
- Protective autoimmunity in cancer
- Vitiligo auto-Abs reduce lung metastases
- Human IgM induce cancer cells apoptosis
- Mechanisms of apoptosis induction by IgM
- A role for IVIM?
- Naturally occurring protective IgG Abs
- Anti-CTLA4 Abs
- Summary
Topics Covered
- Autoimmunity
- Tolerance
- T regulatory cells
- Protective cellular autoimmunity
- Protective humoral autoimmunity
- Protective autoimmunity in autoimmune diseases and cancer
Talk Citation
Toubi, E. (2017, August 11). Protective autoantibodies [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 27, 2024, from https://doi.org/10.69645/YCKN8076.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Elias Toubi has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.